Twelve-Month Outcomes of Simultaneous Translabyrinthine Resection and Cochlear Implantation

被引:5
|
作者
Doerfer, Karl W. [1 ,4 ]
Fritz, Christian G. [2 ]
Porps, Sandra L. [2 ]
Hong, Robert S. [2 ]
Jacob, Jeffrey T. [3 ]
Babu, Seilesh C. [2 ]
机构
[1] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Milwaukee, WI USA
[2] Michigan Ear Inst, Div Neurotol & Lateral Skull Base Surg, Farmington Hills, MI USA
[3] Michigan Head & Spine Inst, Div Skull Base Surg, Southfield, MI USA
[4] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, 8701 Watertown Plank Rd,2nd Floor, Milwaukee, WI 53226 USA
关键词
cochlear implants; single-sided deafness; tinnitus; vestibular schwannoma; VESTIBULAR SCHWANNOMA RESECTION; SENSORINEURAL HEARING-LOSS; SINGLE-SIDED DEAFNESS; QUALITY-OF-LIFE; ACOUSTIC NEUROMA; UNILATERAL DEAFNESS; PRESERVATION; MANAGEMENT; TINNITUS; SURGERY;
D O I
10.1002/ohn.261
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
ObjectiveAudiometric outcomes at 12 months following simultaneous translabyrinthine (TL) resection of vestibular schwannoma (VS) and cochlear implantation (CI). Study DesignProspective cohort study. SettingTertiary referral center. MethodsAdult patients undergoing TL resection of sporadic, unilateral VS <= 2 cm were prospectively enrolled. Preoperative testing included binaural AZBio in noise and quiet and unilateral Consonant-Nucleus-Consonant (CNC). Tinnitus Handicap Index (THI) and Speech, Spatial, and Qualities of Hearing (SSQ) questionnaires were also completed. Patients underwent TL resection with simultaneous CI. The preoperative test battery was repeated at 1, 3, 6, and 12 months after activation. Statistical analysis was performed to characterize short-term outcomes (preoperative to 3 months), longer-term outcomes (3-12 months), and overall changes during the preoperative to 12-month period. ResultsAZBio, CNC, and THI improved at 3 months with no significant changes thereafter and showed durable improvement at 12 months compared to preoperative testing. While SSQ did not improve at 12 months, a subset of patients showed either recovery or improvement of SSQ-spatial subscores. Patients with cerebellopontine angle tumors had poorer performance, although the impact of tumor size and location could not be deduced based on the small sample size. ConclusionPatients undergoing simultaneous CI and TL resection of VS had durable improvements in speech perception and tinnitus severity 12 months following surgery. Subjective improvements in localization were not observed. Additional studies are needed to determine which VS patients are optimal candidates for CI.
引用
收藏
页码:358 / 366
页数:9
相关论文
共 50 条
  • [31] Twelve-Month Labeling Approval for Evolence
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (10) : 960 - 960
  • [32] Effects of twelve-month strength training subsequent to twelve-month stretching exercise in treatment of chronic neck pain
    Ylinen, JJ
    Takala, EP
    Nykänen, MJ
    Kautlainen, HJ
    Häkkinen, AH
    Airaksinen, OVP
    JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2006, 20 (02) : 304 - 308
  • [33] Twelve-month outcomes for heroin dependence treatments: does route of administration matter?
    Darke, S
    Ross, J
    Teesson, M
    DRUG AND ALCOHOL REVIEW, 2005, 24 (02) : 165 - 171
  • [34] Twelve-Month Outcomes of Three Episcleral Surgeries in Treatment of Rhegmatogenous Retinal Detachment
    Zhou, Zigan
    Guo, Binghua
    Zhou, Hantao
    Yang, Chen
    Mei, Jinghao
    Deng, Chuying
    Wu, Ronghan
    Lin, Zhong
    OPHTHALMOLOGICA, 2024, 247 (04) : 214 - 223
  • [35] Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
    Verheye, Stefan
    Vrolix, Mathias
    Montorfano, Matteo
    Zivelonghi, Carlo
    Giannini, Francesco
    Bedogni, Francesco
    Dubois, Christophe
    De Bruyne, Bernard
    Costa, Ricardo A.
    Chamie, Daniel
    Costa Jr, Jose de Ribamar
    Kereiakes, Dean J.
    Abizaid, Alexandre A.
    Colombo, Antonio
    EUROINTERVENTION, 2020, 16 (12) : E974 - +
  • [36] Twelve-Month Outcomes of the First 1000 Days Program on Infant Weight Status
    Taveras, Elsie M.
    Perkins, Meghan E.
    Boudreau, Alexy Arauz
    Blake-Lamb, Tiffany
    Matathia, Sarah
    Kotelchuck, Milton
    Luo, Mandy
    Price, Sarah N.
    Roche, Brianna
    Cheng, Erika R.
    PEDIATRICS, 2021, 148 (02)
  • [37] Twelve-Month Outcomes of Aflibercept vs. Ranibizumab for Wet Macular Degeneration
    Almuhtaseb, Hussein
    Michaels, Luke
    Vardarinos, Thanos
    Lotery, Andrew J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] Twelve-Month Mortality Among Delirium Subtypes
    DeCrane, Susan K.
    Culp, Kennith R.
    Wakefield, Bonnie
    CLINICAL NURSING RESEARCH, 2011, 20 (04) : 404 - 421
  • [39] SCREENING FOR DIABETIC RETINOPATHY - A TWELVE-MONTH REVIEW
    Gracner, Tomaz
    ACTA CLINICA CROATICA, 2020, 59 (03) : 424 - 430
  • [40] Twelve-month outcome of robotic assisted PCI
    Rilinger, J.
    Jeuck, M.
    Maulhardt, T.
    Hartikainen, T.
    Westermann, D.
    Von Zur Muehlen, C.
    EUROPEAN HEART JOURNAL, 2024, 45